High HDL cholesterol does not reliably predict cardiovascular protection or longevity outcomes. The relationship between HDL-C levels and actual disease risk is far weaker than traditional models suggest, requiring more nuanced assessment of lipoprotein function rather than HDL quantity alone.
Key Points
- HDL-C levels correlate poorly with cardiovascular protection.
- Lipoprotein particle function matters more than cholesterol numbers.
- Traditional HDL targets may be clinically misleading.
Longevity Analysis
This work addresses a fundamental problem in cardiovascular risk assessment: the body's signaling mechanisms (how cholesterol transport actually functions) have been misinterpreted through overly simplified biomarkers. Identifying which individuals truly benefit from high HDL requires moving beyond aggregate numbers to understand particle composition, inflammatory load, and functional capacity. This distinction directly shapes intervention strategy—determining whether cholesterol optimization should focus on quantity targets or on restoring the body's ability to manage lipid metabolism and circulation effectively.
Original published by Peter Attia MD, by Peter Attia.